Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bruce C Carleton

Showing results (81-90 of 134) with videos related to

Pageof 14
Sort By:
British Journal of Clinical Pharmacology|March 21, 2017
Pharmacogenomic screening for anthracycline-induced cardiotoxicity in childhood cancerFolefac Aminkeng, Colin J D Ross, Shahrad R Rassekh, et al.
Therapeutic Drug Monitoring|March 10, 2016
Clinical Practice Recommendations for the Management and Prevention of Cisplatin-Induced Hearing Loss Using Pharmacogenetic MarkersJong W Lee, Kusala Pussegoda, Shahrad R Rassekh, et al.
Journal of Clinical Pharmacology|July 25, 2025
Four Pharmacogenomic Variants Strongly Linked to Corticosteroid-Induced Avascular Necrosis in Children with CancerMiguel Cordova-Delgado, Erika N Scott, Shahrad R Rassekh, et al.
Pediatrics|September 15, 2010
Fatal hydrocodone overdose in a child: pharmacogenetics and drug interactionsParvaz Madadi, Doris Hildebrandt, Inna Y Gong, et al.
Therapeutic Drug Monitoring|March 14, 2023
Role of Cisplatin Dose Intensity and TPMT Variation in the Development of Hearing Loss in ChildrenAngela Siemens, Beth Brooks, S Rod Rassekh, et al.
Pharmacogenomics|August 22, 2014
Development of a broad-based ADME panel for use in pharmacogenomic studiesAndrew M K Brown, Yannick Renaud, Colin Ross, et al.
JACC. Cardiooncology|July 3, 2023
<i>RBL2</i> Regulates Cardiac Sensitivity to Anthracycline ChemotherapyPeng Xia, Jingrui Chen, Yadav Sapkota, et al.
PM & R : the Journal of Injury, Function, and Rehabilitation|September 5, 2017
Pharmacogenomic Variability of Oral Baclofen Clearance and Clinical Response in Children With Cerebral PalsyMatthew J McLaughlin, Yang He, Janice Brunstrom-Hernandez, et al.
Clinical Pharmacology and Therapeutics|December 1, 2025
Pathway-Informed Machine Learning Identifies Genetic Predictors of High-Dose Methotrexate-Induced Mucositis in Pediatric Acute Lymphoblastic LeukemiaXiao Yu Cindy Zhang, Erika N Scott, Hedy Maagdenberg, et al.
Computers in Biology and Medicine|November 2, 2024
Machine learning model identifies genetic predictors of cisplatin-induced ototoxicity in CERS6 and TLR4Ali Arab, Bahareh Kashani, Miguel Cordova-Delgado, et al.
Pageof 14

Showing results (81-90 of 134) with videos related to

Sort By:
Pageof 14
British Journal of Clinical Pharmacology|March 21, 2017
Pharmacogenomic screening for anthracycline-induced cardiotoxicity in childhood cancerFolefac Aminkeng, Colin J D Ross, Shahrad R Rassekh, et al.
Therapeutic Drug Monitoring|March 10, 2016
Clinical Practice Recommendations for the Management and Prevention of Cisplatin-Induced Hearing Loss Using Pharmacogenetic MarkersJong W Lee, Kusala Pussegoda, Shahrad R Rassekh, et al.
Journal of Clinical Pharmacology|July 25, 2025
Four Pharmacogenomic Variants Strongly Linked to Corticosteroid-Induced Avascular Necrosis in Children with CancerMiguel Cordova-Delgado, Erika N Scott, Shahrad R Rassekh, et al.
Pediatrics|September 15, 2010
Fatal hydrocodone overdose in a child: pharmacogenetics and drug interactionsParvaz Madadi, Doris Hildebrandt, Inna Y Gong, et al.
Therapeutic Drug Monitoring|March 14, 2023
Role of Cisplatin Dose Intensity and TPMT Variation in the Development of Hearing Loss in ChildrenAngela Siemens, Beth Brooks, S Rod Rassekh, et al.
Pharmacogenomics|August 22, 2014
Development of a broad-based ADME panel for use in pharmacogenomic studiesAndrew M K Brown, Yannick Renaud, Colin Ross, et al.
JACC. Cardiooncology|July 3, 2023
<i>RBL2</i> Regulates Cardiac Sensitivity to Anthracycline ChemotherapyPeng Xia, Jingrui Chen, Yadav Sapkota, et al.
PM & R : the Journal of Injury, Function, and Rehabilitation|September 5, 2017
Pharmacogenomic Variability of Oral Baclofen Clearance and Clinical Response in Children With Cerebral PalsyMatthew J McLaughlin, Yang He, Janice Brunstrom-Hernandez, et al.
Clinical Pharmacology and Therapeutics|December 1, 2025
Pathway-Informed Machine Learning Identifies Genetic Predictors of High-Dose Methotrexate-Induced Mucositis in Pediatric Acute Lymphoblastic LeukemiaXiao Yu Cindy Zhang, Erika N Scott, Hedy Maagdenberg, et al.
Computers in Biology and Medicine|November 2, 2024
Machine learning model identifies genetic predictors of cisplatin-induced ototoxicity in CERS6 and TLR4Ali Arab, Bahareh Kashani, Miguel Cordova-Delgado, et al.
Pageof 14